May 10, 2017 / 12:20 PM / 3 months ago

BRIEF-Inovio pharmaceuticals says AstraZeneca's MedImmune will start new clinical trial

May 10 (Reuters) - Inovio Pharmaceuticals Inc

* Inovio provides update on MedImmune launch of combination trial for hpv-associated head & neck cancer

* Inovio Pharmaceuticals-AstrazZneca's medimmune will start a new clinical trial investigating combination of medi0457

* Inovio Pharmaceuticals-new clinical trial will investigate combination of medi0457 and durvalumab, an investigational pd-l1 checkpoint inhibitor Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below